A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...
Please provide your email address to receive an email when new articles are posted on . There was a significantly heightened likelihood for fractures among children with vs. without asthma. Those with ...
The findings suggest that dampening eosinophilic and T2 inflammatory responses result in increases in several alternative inflammatory pathways that contribute to residual exacerbations in children ...
Please provide your email address to receive an email when new articles are posted on . “At present, we lack noninvasive tests to identify asthma subtypes or endotypes based on these cell types in ...
Credit: Amgen AstraZeneca Tezspire is a first-in-class human monoclonal antibody that works by blocking thymic stromal lymphopoietin. The Food and Drug Administration (FDA) has approved Tezspire™ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results